Individualizing Therapy in CIDP: A Mini-Review Comparing the Pharmacokinetics of Ig With SCIg and IVIg

Immunoglobulin (Ig) therapy is a first-line treatment for CIDP, which can be administered intravenously (IVIg) or subcutaneously (SCIg) and is often required long term. The differences between these modes of administration and how they can affect dosing strategies and treatment optimization need to...

Descripción completa

Detalles Bibliográficos
Autores principales: Beydoun, Said R., Sharma, Khema R., Bassam, Bassam A., Pulley, Michael T., Shije, Jeffrey Z., Kafal, Ayman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7982536/
https://www.ncbi.nlm.nih.gov/pubmed/33763019
http://dx.doi.org/10.3389/fneur.2021.638816

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7982536/
https://www.ncbi.nlm.nih.gov/pubmed/33763019
http://dx.doi.org/10.3389/fneur.2021.638816

Ejemplares similares